Nephrogenic Systemic Fibrosis Risk and Liver Disease

Table 3

In patients with severe renal disease, severe liver disease did not have an association in increasing the risk of NSF. MELD represents the Model for End Stage Liver disease score average.

Characteristics	NSF negative	NSF positive	𝑃 value
Severe renal disease			0.998
Class A and B (MELD avg. 11.7 and 22.5)	13	1
Class C (MELD avg. 33.7)	8	1